Update: Immunotherapeutic Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
The incidence of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) has increased substantially over the past three decades, and since 2017, it has been recognized in the AJCC staging system as distinct from its HPV-negative counterpart. The underlying mechanisms of...
Saved in:
| Main Authors: | Fangdi Sun, A. Dimitrios Colevas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/5/712 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
by: Jason K. Wasserman, et al.
Published: (2017-01-01) -
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma
by: Luc M. Berclaz, et al.
Published: (2025-04-01) -
The results of immunotherapy in patients with recurrent and metastatic human papilloma virus positive head and neck squamous cell carcinoma
by: A. V. Ignatova, et al.
Published: (2024-06-01) -
Clinical characteristics and prognostic impact of HPV infection in head and neck cancer patients in China: a nationwide multicenter study
by: Qi-Jian Zheng, et al.
Published: (2025-07-01) -
HPV-Driven Head and Neck Cancer: The European Perspective
by: Wojciech Golusiński, et al.
Published: (2025-04-01)